24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Molecular and biochemical basis <strong>of</strong> disease<br />

Conclusion: The B haplogoup and the 9 bp small deletion indicate the<br />

east-Asian origin <strong>of</strong> this family which could be explained by the Hungarian<br />

history . The 9 bp deletion may serve as a susceptibility factor for<br />

further mtDNA alterations . We assume that the clinical symptoms are<br />

related to the pathogenic C8270T mutation and the coexistences <strong>of</strong> the<br />

A8347C and A8332G mutations may modify the clinical symptoms .<br />

P05.127<br />

mitochondrial nonsyndromic hearing impairment: the spanish<br />

exception?<br />

D. Feldmann 1 , L. Jonard 1 , A. F. Roux 2 , C. Lemarechal 3 , K. Olszewski 1 , C. Francannet<br />

4 , R. Couderc 1 , F. Denoyelle 1 , S. Marlin 1 ;<br />

1 AP-HP, Paris cedex 12, France, 2 génétique moléculaire IURC, Montpellier,<br />

France, 3 Génétique Inserm U613, Brest, France, 4 génétique médicale, Clermont-Ferrand,<br />

France.<br />

Nonsyndromic sensorineural hearing impairment (NSHI) can be<br />

caused by few mitochondrial mutations . Among these mtDNA mutations,<br />

A1555G mutation in the 12S rRNA gene has been worldly reported<br />

and is associated with NSHI maternally transmitted or with aminoglycoside-induced<br />

NSHI . A high frequency <strong>of</strong> A1555G was observed<br />

in Spain .<br />

From a large cohort <strong>of</strong> NSHI patients studied in the National Reference<br />

Center for Genetic Deafness in Paris, France, we selected 156<br />

unrelated patients with NSHI maternally inherited and 124 sporadic<br />

NSHI exposed to aminoglycosides before hearing loss onset . A1555G<br />

was studied by PCR-restriction enzyme analysis and confirmed by sequencing<br />

. Absence <strong>of</strong> GJB2 mutations and GJB6 deletions was verified.<br />

A1555G mutation was observed in 7 <strong>of</strong> the 156 NSHI familial cases<br />

(4,5%) and in 0 <strong>of</strong> the 124 sporadic cases . The 7 families with A1555G<br />

originated respectively from China, Martinique, Arab/Israel, Portugal,<br />

Iran, Madagascar and Spain . Homoplasmic A1555G mutation was detected<br />

in all the descendants <strong>of</strong> the oldest studied mother . The HI was<br />

present in 51 <strong>of</strong> the 102 maternal relatives . The calculated penetrance<br />

<strong>of</strong> A1555G in this study is 50% . The HI was very heterogeneous with<br />

an onset ranging from 0 to 30 years and a severity varying from mild<br />

to pr<strong>of</strong>ound .<br />

This study shows that the frequency <strong>of</strong> A1555G in NSHI maternally<br />

inherited is lower in France than in Spain (4,5% versus 61%) and in<br />

sporadic cases (0 versus 3%) . This reported variability could be due to<br />

the different use <strong>of</strong> aminoglycoside antibiotics in the two countries or<br />

to genetics factors .<br />

P05.128<br />

mitochondrial AtPase 6 gene as a hot spot for<br />

Neurodegenerative disorders?<br />

M. Banoei, M. Houshmand;<br />

National Institute <strong>of</strong> Genetic Engineering and Biotechnology, Tehran, Islamic<br />

Republic <strong>of</strong> Iran.<br />

The mitochondrial DNA (mtDNA) may play an essential role in the<br />

pathogenesis <strong>of</strong> the respiratory chain complex activities in neurodegenerative<br />

disorders such as Huntington’s disease (HD), Spinocerebellar<br />

Ataxias (SCA), and Multiple Sclerosis (MS), Ataxia-Telangiectasia<br />

(AT), Friedreish’s Ataxia (FA) and Duchene Muscular Dystrophy<br />

(DMD) as neuromuscular disease . Dysfunction <strong>of</strong> the mitochondrial<br />

Respiratory Chain (RC) has been shown in patients with neurological<br />

disorders . the tRNA genes mutations are one <strong>of</strong> hot spots that cause<br />

mitochondrial disorders .<br />

To determine mtDNA damage, we investigated deletions based in four<br />

areas <strong>of</strong> mitochondrial DNA, in a group <strong>of</strong> 120 patients clinically diagnosed<br />

with one <strong>of</strong> mentioned neurological disorders . We screened<br />

for tRNA Leu , tRNA Lys , COII, ATPase6/8 and NDI genes <strong>of</strong> mtDNA <strong>of</strong><br />

patients with HD, SCA, MS, AT, FA and DMD .<br />

Results showed that ATPase 6 gene is a hot spot region rather than<br />

other regions . Several new nucleotide variations resulting in amino<br />

acid changes were observed in patients that altered protein structure<br />

regarding to essential changes in amino acids .<br />

The secondary mitochondrial respiratory chain defects encountered in<br />

these disorders can also be explained by mitochondrial that degenerate<br />

either as part <strong>of</strong> a more widespread cellular insult, or as a consequence<br />

<strong>of</strong> a different specific defect. Most mitochondrial proteins have<br />

to be imported from the cytoplasm and directed to the mitochondria .<br />

So this study suggests that the high rate <strong>of</strong> mutations in ATPase 6<br />

could be result in interaction <strong>of</strong> nuclear protein with mtDNA genome .<br />

P05.129<br />

screening for mELAs mutations in italian patients having strokelike<br />

episodes<br />

V. Andreoli 1 , F. Trecroci 1 , A. Nucera 2 , A. La Russa 1 , M. Liguori 1 , I. Manna 1 , P.<br />

Spadafora 1 , M. Caracciolo 1 , G. Di Palma 1 , R. Cittadella 1 ;<br />

1 Institute <strong>of</strong> Neurological Sciences-National Research Council, Pianolago di<br />

Mangone (CS), Italy, 2 Stroke Unit- Neurology, Santa Maria Nuova Hospital,<br />

Reggio Emilia, Italy.<br />

Mitochondrial encephalomyopathies are a multisystemic group <strong>of</strong> disorders<br />

that are characterised by a wide range <strong>of</strong> clinical, biochemical,<br />

and genetic mitochondrial defects . Among this group <strong>of</strong> disorders, the<br />

Mitochondrial myopathy, Encephalopathy, Lactic Acidosis with Strokelike<br />

episodes (MELAS) syndrome is one <strong>of</strong> the most frequently occurring<br />

maternally inherited mitochondrial disorders . The age <strong>of</strong> onset is<br />

highly variable and it is very rare in patients over the age <strong>of</strong> 40 . Mutations<br />

in tRNA, especially A3243G in the MTTL1 (tRNA Leu ) gene, are<br />

accounted for more than 80% <strong>of</strong> the cases and other mtDNA mutations<br />

such as T3271C have also been described . We analyzed 55 Italian<br />

patients clinically exhibiting stroke-like episodes, migraine, ataxia and<br />

dementia for the two primary mutations mentioned above in the MT-<br />

TL1 gene. This molecular investigation was carried out using PCR-<br />

RFLP with the restriction endonuclease Apa I and Afl II respectively .<br />

None <strong>of</strong> the patients or the 25 controls subjects, matched for ethnic<br />

background, gender and age, were found to carry these mutations<br />

(A3243G and T3271C) in homoplasmic/heteroplasmic form . However,<br />

after direct sequencing <strong>of</strong> the MT-TL1 gene and a part <strong>of</strong> the MT-ND1<br />

gene, we no detected mt-mutations in the tested patients and controls<br />

and we confirmed that MELAS is an extremely rare disease . Moreover,<br />

we also found a A3480G synonymous variation in the MT-ND1 in a<br />

51- year-old man, whose medical history was significant for ischemic<br />

stroke <strong>of</strong> undetermined origin and increase in lactate level in blood .<br />

P05.130<br />

two novel mitochondrial DNA mutations in muscle tissue <strong>of</strong> a<br />

patient with limb-girdle myopathy<br />

S. Seneca 1 , A. Meulemans 2 , B. De Paepe 3 , J. De Bleecker 4 , J. Smet 3 , L. De<br />

Meirleir 5 , W. Lissens 1 , R. Van Coster 3 , I. Liebaers 1 ;<br />

1 Center for Medical <strong>Genetics</strong>, UZ Brussel, Brussels, Belgium, 2 Department <strong>of</strong><br />

Pediatrics, ULB, Brussels, Belgium, 3 Department <strong>of</strong> Neurology & Pediatric Neurology<br />

and Metabolism, Ghent University Hospital, Gent, Belgium, 4 Department<br />

<strong>of</strong> Neurology, Ghent University Hospital, Gent, Belgium, 5 Department <strong>of</strong> Pediatrics<br />

& Center for Medical <strong>Genetics</strong>, UZ Brussel, Brussels, Belgium.<br />

Patients with an oxidative phosphorylation (OXPHOS) disorder <strong>of</strong>ten<br />

present with complex clinical features, including neurological and<br />

muscular dysfunction . Mutations underlying these diseases are located<br />

in the mitochondrial or nuclear genome . Here, we report on a<br />

forty-eight-year-old woman suffering from mild limb girdle myopathy .<br />

The enzymatic activities <strong>of</strong> the OXPHOS enzymes in skeletal muscle<br />

tissue <strong>of</strong> the patient were within the control ranges . However, activity<br />

staining following BN-PAGE showed a decreased complex III activity<br />

and the presence <strong>of</strong> complex V subcomplexes . Immunocytochemistry<br />

demonstrated a mosaic staining pattern in a minority (about 20%) <strong>of</strong><br />

the muscle fibers for complex I (subunit 20kd) and complex IV (subunit<br />

I). Molecular analyses identified two novel heteroplasmic mitochondrial<br />

DNA nucleotide aberrations in muscle tissue : an insertion,<br />

m .5888insA in the mt-tRNA Tyr gene and an alteration, m .14639A>G,<br />

changing a leucine into a serine residue in the ND6 gene . Less than<br />

1% <strong>of</strong> both mutant alterations were present in the patient‘s fibroblasts,<br />

while they were undetectable in her blood and in blood and fibroblasts<br />

from her mother .<br />

Single muscle fiber analyses clearly demonstrated that COX-deficient<br />

fibers, as compared to COX-positive fibers, harbored a significantly<br />

higher level <strong>of</strong> both mtDNA mutations . These results, together with<br />

previously defined canonical criteria determining the pathogenic character<br />

<strong>of</strong> mtDNA analyses, suggest that both nucleotide changes are<br />

pathogenic mutations .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!